ATE557041T1 - Peptid-vakzinen gegen streptokokken der gruppe a - Google Patents

Peptid-vakzinen gegen streptokokken der gruppe a

Info

Publication number
ATE557041T1
ATE557041T1 AT02734477T AT02734477T ATE557041T1 AT E557041 T1 ATE557041 T1 AT E557041T1 AT 02734477 T AT02734477 T AT 02734477T AT 02734477 T AT02734477 T AT 02734477T AT E557041 T1 ATE557041 T1 AT E557041T1
Authority
AT
Austria
Prior art keywords
peptides
antibodies
compositions
vaccines
relates
Prior art date
Application number
AT02734477T
Other languages
English (en)
Inventor
Bernard Beall
George Carlone
Jacquelyn Sampson
Edwin Ades
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE557041T1 publication Critical patent/ATE557041T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AT02734477T 2001-05-18 2002-05-20 Peptid-vakzinen gegen streptokokken der gruppe a ATE557041T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29183501P 2001-05-18 2001-05-18
PCT/US2002/015909 WO2002094851A2 (en) 2001-05-18 2002-05-20 Peptide vaccines against group a streptococci

Publications (1)

Publication Number Publication Date
ATE557041T1 true ATE557041T1 (de) 2012-05-15

Family

ID=23122046

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02734477T ATE557041T1 (de) 2001-05-18 2002-05-20 Peptid-vakzinen gegen streptokokken der gruppe a

Country Status (5)

Country Link
US (5) US7407664B2 (de)
EP (1) EP1399181B1 (de)
AT (1) ATE557041T1 (de)
CA (2) CA2881980A1 (de)
WO (1) WO2002094851A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG165981A1 (en) 2000-10-27 2010-11-29 Chiron Srl Nucleic acids and proteins from streptococcus groups a & b
ATE557041T1 (de) * 2001-05-18 2012-05-15 Us Gov Health & Human Serv Peptid-vakzinen gegen streptokokken der gruppe a
US20070053924A1 (en) * 2002-08-26 2007-03-08 Herve Tettelin Conserved and specific streptococcal genomes
US7709009B2 (en) * 2003-07-31 2010-05-04 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for streptococcus pyogenes
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
EP1768662A2 (de) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immunstimulatoren kleiner moleküle und assays für deren nachweis
CA2571421A1 (en) 2004-06-24 2006-01-05 Nicholas Valiante Compounds for immunopotentiation
JP2008508320A (ja) 2004-07-29 2008-03-21 カイロン コーポレイション Ｓｔｒｅｐｔｏｃｏｃｃｕｓａｇａｌａｃｔｉａｅのようなグラム陽性細菌に対する免疫原性組成物
AU2005294275B2 (en) * 2004-10-08 2012-09-13 Glaxosmithkline Biologicals S.A. Immunogenic and therapeutic compositions for Streptococcus pyogenes
WO2007047749A1 (en) 2005-10-18 2007-04-26 Novartis Vaccines And Diagnostics Inc. Mucosal and systemic immunizations with alphavirus replicon particles
WO2007081447A2 (en) 2005-11-22 2007-07-19 Novartis Vaccines And Diagnostics, Inc. Norovirus and sapovirus antigens
EP2368570A3 (de) 2006-01-18 2012-05-02 University Of Chicago Zusammensetzungen und Verfahren in Verbindung mit Stayphylokokken-Bakterienproteinen
CA2646539A1 (en) 2006-03-23 2007-09-27 Novartis Ag Imidazoquinoxaline compounds as immunomodulators
ATE522541T1 (de) * 2006-06-09 2011-09-15 Novartis Ag Bakterielle adhäsine konformere
WO2008108830A2 (en) * 2006-10-30 2008-09-12 Novartis Ag Immunogenic and therapeutic compositions for streptococcus pyogenes
EP2173902A4 (de) * 2007-07-03 2013-01-09 Mt Sinai Hospital Therapeutika und diagnostika für gruppe-a-streptokokken
GB0713880D0 (en) 2007-07-17 2007-08-29 Novartis Ag Conjugate purification
ES2561483T3 (es) 2007-09-12 2016-02-26 Glaxosmithkline Biologicals Sa Antígenos mutantes de GAS57 y anticuerpos de GAS57
KR101773114B1 (ko) 2007-12-21 2017-08-30 노파르티스 아게 스트렙토라이신 ｏ의 돌연변이 형태
US8465751B2 (en) 2009-01-12 2013-06-18 Novartis Ag Cna—B domain antigens in vaccines against gram positive bacteria
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
US9517263B2 (en) 2009-06-10 2016-12-13 Glaxosmithkline Biologicals Sa Benzonaphthyridine-containing vaccines
EP2443250B8 (de) 2009-06-16 2016-09-21 GlaxoSmithKline Biologicals SA Komplement-vermittelte antikörper-abhängige und opsonische bakterienassays mit hohem durchlauf
TWI445708B (zh) 2009-09-02 2014-07-21 Irm Llc 作為ｔｌｒ活性調節劑之化合物及組合物
MX2012002723A (es) 2009-09-02 2012-04-11 Novartis Ag Composiciones inmunogenicas que incluyen moduladores de la actividad de receptores tipo toll.
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
ES2631977T3 (es) 2009-12-15 2017-09-07 Glaxosmithkline Biologicals Sa Suspensión homogénea de compuestos inmunopotenciadores y usos de la misma
KR101853513B1 (ko) 2010-03-23 2018-04-30 노파르티스 아게 감염, 염증, 호흡기 질환 등의 치료를 위해 사용되는 ｔｌｒ2 효능제로서의 화합물 (시스테인 기재 리포펩티드) 및 조성물
KR20130121699A (ko) 2010-05-28 2013-11-06 테트리스 온라인, 인코포레이티드 상호작용 혼성 비동기 컴퓨터 게임 기반구조
US9192661B2 (en) 2010-07-06 2015-11-24 Novartis Ag Delivery of self-replicating RNA using biodegradable polymer particles
US8697085B2 (en) 2011-06-17 2014-04-15 University Of Tennessee Research Foundation Group A Streptococcus multivalent vaccine
TR201807340T4 (tr) 2013-02-01 2018-06-21 Glaxosmithkline Biologicals Sa Çan benzeri reseptör agonistleri içeren immünolojik kompozisyonların intradermal yoldan verilmesi.
CA2898834A1 (en) 2013-02-11 2014-08-14 James B. Dale Group a streptococcal m-related proteins and methods of use
IL276608B2 (en) 2018-02-12 2024-04-01 Inimmune Corp TOLL-like receptor ligands
SG11202011348YA (en) * 2018-05-16 2020-12-30 Univ Griffith Streptococcal toxic shock syndrome
WO2022096590A1 (en) 2020-11-04 2022-05-12 Eligo Bioscience Phage-derived particles for in situ delivery of dna payload into c. acnes population

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
CA2123579C (en) * 1992-09-16 2005-05-10 James B. Dale Recombinant multivalent m protein vaccine
AU5128593A (en) * 1992-09-16 1994-04-12 University Of Tennessee Research Corporation, The Antigen of hybrid m protein and carrier for group a streptococcal vaccine
WO1999013084A1 (en) * 1997-09-12 1999-03-18 Id Vaccine Group a streptococcal vaccines
US6716433B1 (en) * 1997-09-12 2004-04-06 University Of Tennessee Research Foundation Group a streptococcal vaccines
ATE557041T1 (de) * 2001-05-18 2012-05-15 Us Gov Health & Human Serv Peptid-vakzinen gegen streptokokken der gruppe a

Also Published As

Publication number Publication date
US20110110969A1 (en) 2011-05-12
EP1399181B1 (de) 2012-05-09
WO2002094851A3 (en) 2003-10-30
US7407664B2 (en) 2008-08-05
CA2447599A1 (en) 2002-11-28
CA2881980A1 (en) 2002-11-28
EP1399181A2 (de) 2004-03-24
US20050220808A1 (en) 2005-10-06
CA2447599C (en) 2015-04-28
US7883710B2 (en) 2011-02-08
US8420107B2 (en) 2013-04-16
US20120177685A1 (en) 2012-07-12
EP1399181A4 (de) 2006-06-28
US20080279880A1 (en) 2008-11-13
US8637050B2 (en) 2014-01-28
US20130202635A1 (en) 2013-08-08
WO2002094851A2 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
ATE557041T1 (de) Peptid-vakzinen gegen streptokokken der gruppe a
WO2004099231A3 (en) Glycopegylation methods and proteins/peptides produced by the methods
DE60238472D1 (de) Abschwächung der immunogenizität von fusionsproteinen
WO2004006952A3 (en) Therapeutic tuberculosis vaccines
NZ521396A (en) Fusion proteins comprising two or more Neisseria polypeptides
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
IS6722A (is) Samsetning bóluefnis
WO2002074795A3 (en) Oligomeric complexes of chimeric proteins with enhanced immunogenic potential
CY1106875T1 (el) Αντιγονικα πεπτιδια απο neisseria
WO2003065973A3 (en) Multivalent streptococcal vaccine compositions and methods for use
WO2001079274A8 (en) Tuberculosis antigens and methods of use thereof
DK1530637T3 (da) Carlsberg-subtilisin-proteiner med nedsat immunogenitet
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
WO2007029262A3 (en) Compositions and methods using same for the detection of viruses
NZ535908A (en) HIV regulatory and auxilliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
WO2009074318A3 (en) Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies
DE60234475D1 (de) Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
DE60127113D1 (de) Gd3 mimetische peptide
WO2003038061A3 (en) Ehrlichia disulfide bond formation proteins and uses thereof
ATE338126T1 (de) Dna-sequenz und rekombinante herstellung eines graminaen-allergens
WO2007030771A3 (en) Targeted identification of immunogenic peptides
WO2004056316A8 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
ATE427955T1 (de) Zusammensetzungen und verfahren zur erfassung von stress induzierten proteinen
WO2005062871A3 (en) Tat linear epitope peptides and conjugates thereof for use in therapeutic compositions and assays
WO2002051865A3 (fr) Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih